Amended Current Report Filing (8-k/a)
January 26 2017 - 2:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off
The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
October 12, 2016
NEUROMAMA, LTD.
(Exact name of registrant as specified
in charter)
Nevada
|
333-180750
|
98-0706304
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Blvd. Benito Juarez Km 25.500,
Quinta Del Mar, Int. Suite 28
Playas de Rosarito B.C,
Mexico
|
c.p. 22710
|
(Address of principal executive offices)
|
(Zip Code)
|
+52 (664) 290-5048
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ W
ritten
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ S
oliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
☐ P
re-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐ P
re-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Explanatory Note
This Form 8-K/A amends the Form 8-K
the Registrant filed with the Commission on January 19, 2017 to correct and clarify some disclosures that were made in the Form
8-K.
Item 4.01 Changes in Registrant’s Certifying
Accountant.
(a) On October 12, 2016, the Board of Directors of Neuromama,
Ltd. (the "Company") dismissed MaloneBailey, LLP (“MaloneBailey”) as the principal accountant for the Company.
MaloneBailey did not issue any reports on the Company's financial statements for either of the past two years or subsequent interim
period.
There were no disagreements between the Company and MaloneBailey,
for the two most recent fiscal years and any subsequent interim period through October 12, 2016 (date of dismissal) on any matter
of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.
(b) On October 13,
2016, the Board of Directors of the Company approved the engagement of Keeton CPA (“Keeton”) as its principal accountant
to audit the Company’s financial statements as successor to MaloneBailey. During the Company's two most recent fiscal years
or subsequent interim period, the Company has not consulted with the entity of Keeton regarding the application of accounting principles
to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial
statements, nor did the entity of Keeton provide advice to the Company, either written or oral, that was an important factor considered
by the Company in reaching a decision as to the accounting, auditing or financial reporting issue.
Further, during the Company's two most recent fiscal years
or subsequent interim period, the Company has not consulted the entity of Keeton on any matter that was the subject of a disagreement
or a reportable event.
Item 9.01 Financial Statements and Exhibits.
Exhibit
Number Description
16.1
Letter from MaloneBailey dated
January 26, 2017 regarding change in certifying accountant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NEUROMAMA, LTD.
|
|
|
|
|
|
Date: January 26, 2017
|
By:
|
/s/ Igor Weselovsky
|
|
|
|
Igor Weselovsky, President, Chief Executive Officer & Director
|
|